Trial Profile
Differential effects of teriparatide and strontium ranelate on bone remodeling and formation in postmenopausal women with osteoporosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Strontium ranelate
- Indications Osteoporosis
- Focus Pharmacodynamics
- Sponsors Eli Lilly and Company
- 31 Mar 2006 New trial record.